Table 4.
Follow-up status of patients 1 and 3 mo after operation, n (%)
|
Follow-up status
|
D-TACE (15 cases)
|
C-TACE (58 cases)
|
χ
2
value
|
P
value
|
| Efficacy evaluation one month postoperative | 3.307 | 0.347 | ||
| CR | 2 (13.3) | 20 (34.5) | ||
| PR | 8 (53.3) | 21 (36.2) | ||
| SD | 3 (20.0) | 7 (12.1) | ||
| PD | 2 (13.3) | 10 (17.2) | ||
| Evaluation of curative effect in 3 mo postoperative | 4.091 | 0.252 | ||
| CR | 2 (13.3) | 18 (31.0) | ||
| PR | 7 (46.7) | 21 (36.2) | ||
| SD | 0 (0.0) | 5 (8.6) | ||
| PD | 6 (40.0) | 14 (24.1) | ||
| Number of interventional treatments | 10.444 | 0.005 | ||
| 1 | 15 (100.0) | 32 (55.2) | ||
| 2 | 0 (0.0) | 24 (41.4) | ||
| 3 | 0 (0.0) | 2 (3.4) |
D-TACE: Drug-loaded microspheres transcatheter arterial chemoembolization; C-TACE: Traditional/conventional transcatheter arterial chemoembolization; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Disease progression.